On October 18, the 2026 World Traditional Medicine Conference Parallel Forum - Traditional Medicine Regulation and Industrial Innovation Development Forum was held in Beijing. Yang Sheng, member of the party group and deputy director of the State Drug Administration, attended and delivered a speech. In his speech, Yang Sheng proposed to guarantee the quality and safety of traditional medicines through high-level supervision, promote international exchanges of traditional medicine through standard coordination, promote innovation in the traditional medicine industry through scientific and technological empowerment, promote civilized exchanges of traditional medicine through mutual learning and mutual appreciation, and make new and greater contributions to building a human health community. The forum brought together more than 300 representatives from more than 10 countries and regions, including China, Europe, Africa, the United States, Brazil, Indonesia, Malaysia, Pakistan, and Serbia, as well as Hong Kong and Macao regulators, relevant international organizations, academia and industry to focus on the two major topics of international registration and standard coordination of traditional medicines, post-marketing quality supervision and pharmacovigilance, and exchange on traditional drug regulations, standard systems and drug life cycle management practices. The forum formed a consensus outcome document “Good Regulation Promotes Access to Quality Traditional Medicines”.

On October 18, the 2026 World Traditional Medicine Conference Parallel Forum - Traditional Medicine Regulation and Industrial Innovation Development Forum was held in Beijing. Yang Sheng, member of the party group and deputy director of the State Drug Administration, attended and delivered a speech. In his speech, Yang Sheng proposed to guarantee the quality and safety of traditional medicines through high-level supervision, promote international exchanges of traditional medicine through standard coordination, promote innovation in the traditional medicine industry through scientific and technological empowerment, promote civilized exchanges of traditional medicine through mutual learning and mutual appreciation, and make new and greater contributions to building a community of human health. The forum brought together more than 300 representatives from more than 10 countries and regions, including China, Europe, Africa, the United States, Brazil, Indonesia, Malaysia, Pakistan, and Serbia, as well as Hong Kong and Macao regulators, relevant international organizations, academia and industry to focus on the two major topics of international registration and standard coordination of traditional medicines, post-marketing quality supervision and pharmacovigilance, and exchange on traditional drug regulations, standard systems and drug life cycle management practices. The forum formed a consensus outcome document “Good Regulation Promotes Access to Quality Traditional Medicines”.